Skip to main content
grasp.study
About
Explore
Pricing
Log in
Try it for free
Back to course
👋
Welcome to a Grasp lesson
Create a free account
to keep studying and create your own study path.
GLP-1 Receptor Agonist Biology
·
Module 3
Established Benefits, Weight Trajectories, and Body Composition
1
Interpreting Clinical-Trial Results: Absolute, Relative, and Confidence-Interval Effects
Interpret a clinical-trial result using absolute and relative effects and a plain-language explanation of its confidence interval.
2
Cardiovascular and Kidney Benefits of Selected GLP-1 and Dual GIP/GLP-1 Outcome Trials
Identify the cardiovascular and kidney benefits established by selected outcome trials for the particular drug and population studied, without generalizing automatically to all GLP-1 or dual GIP/GLP-1 agonists.
3
Interpreting Weight Trajectories Without Assuming Permanence or Guaranteed Responses
Interpret weight trajectories during treatment and after withdrawal without assuming permanent effects or guaranteed individual responses.
4
Interpreting Fat and Lean Mass Changes Accurately
Interpret changes in fat mass and lean mass without equating measured lean-mass loss with skeletal-muscle loss or impaired strength.
Previous module
How GLP-1 Signalling Changes Glucose, Digestion, and Appetite
Next module
Adverse Effects and the Limits of Safety Evidence